Marvell Stock Rallies as AI Demand Lifts 2028 Revenue Target to $20 Billion
Marvell’s MRVL shares rallied as the chipmaker targeted $20 billion in fiscal 2028 revenue and $70–90 billion by fiscal 2031 on growing AI demand.
Daniel Wright covers U.S. equities, earnings cycles, and sector rotation at MarketSpeaker, focusing on institutional positioning, valuation resets, and the catalysts that drive short- and medium-term market direction. He tracks earnings revisions, liquidity conditions, and capital flows to distinguish durable trends from short-lived rallies, delivering concise, data-driven analysis for investors. Outside the newsroom, Daniel is an avid long-distance runner and follows college basketball closely; he lives in New York and spends weekends exploring independent bookstores and coffee shops with friends.
Marvell’s MRVL shares rallied as the chipmaker targeted $20 billion in fiscal 2028 revenue and $70–90 billion by fiscal 2031 on growing AI demand.
Meta’s Muse is sharpening investor interest in AMD as personal AI agents create demand for server CPUs alongside the GPUs powering their models.
SpaceX rises nearly 6% as its estimated valuation reaches $2.22 trillion, with Morgan Stanley maintaining a $300 target ahead of the next Starship test.
Cerebras shares rise 6.3% to $177 in premarket trading after Sam Altman reaffirms the OpenAI partnership, following a sharp selloff over Nvidia deployment.
Disney’s reported TV restructuring puts DIS shareholders’ focus on streaming margins, execution costs and cash returns after the October 1 share decline.
Nvidia reaches a new intraday record, taking its estimated market value above $5.72 trillion as investors assess AI earnings and a larger buyback program.
Nike plans job cuts from 2027 as Greater China sales fall 22%, deepening a restructuring aimed at reducing costs and rebuilding its marketplace.
Nike shares fell about 5% after its results, extending a slide to 13-year lows as a revenue miss and weak annual outlook overshadowed an earnings beat.
Accenture and Synopsys rally on financial updates, Vicor lifts its outlook, and a patent ruling sends United Therapeutics and Liquidia in opposite directions.
Nvidia expands its buyback authorization by $150 billion as AI earnings surge, with $235 billion now available for repurchases through fiscal 2028.